*Advance our knowledge of the basic immunology of inflammation, autoimmunity, cancer, transplantation and infection and to translate this new knowledge to novel strategies for diagnosis, prevention and therapeutic intervention.
*Foster collaborations and further strengthen interactions among the Penn community of immunologists.
Spotlights on IFI
*Congratulations to this year's Institute for Immunology Pilot Grant Awardees*
PI: Maayan Levy, PhD: Microbiome control of the human AMPome
PI: Christoph Thaiss, PhD: New Elements of the Human Adipose Immunone
*Carl June Named One of TIME’s 100 Most Influential People in the World*
TIME named Carl June, MD, a professor of Pathology and Laboratory Medicine and director of the Center for Cellular Immunotherapies in the Abramson Cancer Center, to its list of the 100 most influential people in the world in recognition of his pioneering work in the development of CAR T-cell therapy. Emily Whitehead, the first pediatric patient to receive the treatment, wrote the tribute associated with the honor.
What's happening in IFI
Congratulations to this year's Institute for Immunology Pilot Grant Awardees: Maayan Levy, PhD and Christoph Thaiss, PhD!
Penn IFI 19 hours, 51 minutes ago
Penn IFI 19 hours, 53 minutes ago
Penn IFI 19 hours, 55 minutes ago